Liver transplantation and hepatitis viruses

  • R. Williams
  • J. G. O’Grady
  • S. E. Davies
  • E. Fagan
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)


Considerations regarding liver transplantation in viral-hepatitis-related acute liver failure and end-stage chronic liver disease are discussed. Parameters of prognosis and indications for transplantation are presented. Differences according to the causative agent are noted, in particular regarding the danger of reinfection. The role of immunoprophylaxis is addressed as is the question of additional antiviral (interferon) treatment.


Liver Transplantation Orthotopic Liver Transplantation Acute Liver Failure Fulminant Hepatic Failure Fulminant Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Iwatsuki S, Starzl TE, Gordon TE et al (1988) Experience of 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Trans Proc 20: 498–504Google Scholar
  2. 2.
    Busuttil RW, Colonna JO, Hiatt JR et al (1987) The first 100 liver transplants at UCLA. Ann Surg 206: 387–402PubMedCrossRefGoogle Scholar
  3. 3.
    Krom RAF, Wiesner RH, Rettke SR et al (1989) The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 94: 84–94Google Scholar
  4. 4.
    Peleman RR, Gavaler JS, Van Thiel DH et al (1987) Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 7: 484–489PubMedCrossRefGoogle Scholar
  5. 5.
    Bismuth H, Samuel D, Gugenheim J et al (1987) Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 107: 337–341PubMedGoogle Scholar
  6. 6.
    Vickers C, Neuberger J, Buckels J, McMaster P, Elias E (1988) Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7: 143–150PubMedCrossRefGoogle Scholar
  7. 7.
    O’Grady JG, Alexander GJM, Thick M, Potter D, Calne RY, Williams R (1988) Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med 69: 817–824Google Scholar
  8. 8.
    Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL (1989) Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 96: 1583–1588PubMedGoogle Scholar
  9. 9.
    O’Grady JG, Gimson AES, O’Brien CJ, Pucknell A, Hughes R, Williams R (1988) Controlled trials of charcoal hemoperfusion and prognostic indicators in fulminant hepatic failure. Gastroenterology 94: 1186–1192PubMedGoogle Scholar
  10. 10.
    O’Grady JG, Alexander GJM, Hallyar K, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–435PubMedGoogle Scholar
  11. 11.
    Bernuau J, Goudeau A, Poynard T et al (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6: 648–651PubMedCrossRefGoogle Scholar
  12. 12.
    Fagan E, Brahm J, Mann G, et al (1990) Persistence of hepatitis A virus before and after liver transplantation for fulminant hepatitis. J Med Virol 30: 131–136PubMedCrossRefGoogle Scholar
  13. 13.
    Gimson AES, Tedder RS, White YS, Eddelston ALWF, Williams R (1983) Serological markers in fulminant hepatitis B. Gut 24: 615–617PubMedCrossRefGoogle Scholar
  14. 14.
    Brechot C, Bernuau J, Thiers V et al (1984) Multiplication of hepatitis B virus in fulminant hepatitis B. Br Med J 288: 270–271CrossRefGoogle Scholar
  15. 15.
    Vogel W, Dietze O, Judmaier G, Then P, Schmid Th, Margreiter R (1988) Delayed clearance of HBsAg after transplantation for fulminant delta-hepatitis (letter). Lancet i: 52CrossRefGoogle Scholar
  16. 16.
    Kuo G, Choo Q-L, Alter H J et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364PubMedCrossRefGoogle Scholar
  17. 17.
    O’Grady J, Smith HM, Sutherland S, Sheron N, Williams R (1990) Low detection of hepatitis C antibodies in serum after liver transplantation. J Hepatol 11: S47 (Abstract)CrossRefGoogle Scholar
  18. 18.
    Trainor T, Farr G, Cooper S, et al (1990) Antibody to hepatitis C (Anti-HCV) in orthotopic liver transplant recipients. Hepatology 12: 886 (Abstract)Google Scholar
  19. 19.
    Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362PubMedCrossRefGoogle Scholar
  20. 20.
    Fagan EA, Ellis DS, Tovey et al (1989) Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B. J Med Virol 28: 150–155PubMedCrossRefGoogle Scholar
  21. 21.
    Fagan EA, Ellis DS, Portmann B, Tovey GM, Williams R, Zuckerman AJ (1987) Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantation. J Med Virol 22: 189–198PubMedCrossRefGoogle Scholar
  22. 22.
    Colombo M, Kuo G, Choo L et al (1989) High prevalence of antibody to hepatitis C virus in patients with hepatocellular carcinoma (abstract). J Hepatol 9Google Scholar
  23. 23.
    Bonino F, Kuo G, Brunetto MR et al (1989) Antibody to hepatitis C virus in the serum of patients with chronic hepatitis (abstract). J Hepatol 9Google Scholar
  24. 24.
    Donovan JP, Markin RS, Zetterman RK, et al (1989) Non-A, non-B hepatitis after orthotopic liver transplantation. Hepatology 10: 569 (Abstract)CrossRefGoogle Scholar
  25. 25.
    O’Grady JG, Smith HM, Davies SE, et al (submitted for publication) Hepatitis B virus reinfection after orthotopic liver transplantation: serological and clinical implicationsGoogle Scholar
  26. 26.
    Davies S, Portmann B, O’Grady JG, et al (1991) Hepatic histological findings after liver transplantation for chronic hepatitis B virus infection including an unique pattern of fibrosing cholestatic hepatitis. Hepatology 13: 150–157PubMedCrossRefGoogle Scholar
  27. 27.
    Lauchart W, Müller R, Pichlmayr R (1987) Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Trans Proc 19: 2387–2389Google Scholar
  28. 28.
    Reynes M, Zignego L, Samuel D et al (1989) Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis. Trans Proc 21: 2424–2425Google Scholar
  29. 29.
    Colledan M, Grendele M, Gridelli B et al (1989) Long-term results after liver transplantation in B and delta hepatitis. Trans Proc 21: 2421–2423Google Scholar
  30. 30.
    Rakela J, Wooten RS, Batts KP, Perkins JD, Taswell HF, Krom RAF (1989) Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 64: 429–432PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • R. Williams
    • 1
  • J. G. O’Grady
    • 1
  • S. E. Davies
    • 1
  • E. Fagan
    • 1
  1. 1.Institute of Liver StudiesKing’s College School of Medicine and DentistryLondonUK

Personalised recommendations